Picture of Instil Bio logo

TIL — Instil Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Instil Bio Inc expected to post a loss of $2.23 a share - Earnings Preview

* Instil Bio Inc  TIL.OQ   TIL.O  is expected to show no
change in
quarterly revenue when it reports  results on May 9 (estimated)
for the period ending January 1 0001
    * 
    * ​LSEG's mean analyst estimate for Instil Bio Inc is for a
loss
of $2.23 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Instil Bio
Inc is
$18.00​, above​ its last closing price of $11.54. ​​​

This summary was machine generated May 7 at 12:34 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Instil Bio

See all news